论文部分内容阅读
为测定米非司酮对健康的足月妊娠妇女促使宫颈成熟和引产的最佳剂量和评价母体、胎儿及新生儿对米非司酮耐受性,收集1992年5月—1995年11月法国8个研究中心的足月妊娠妇女,进行随机双盲安慰剂对照研究。选择的研究对象为单胎妊娠,头先露,孕龄37～41周加3d,宫颈不成熟,48h以内(
To determine the optimal dose of mifepristone for healthy full-term pregnant women to promote cervical maturation and induction of labor and to evaluate the mifepristone tolerance of maternal, fetal and neonatal subjects collected from May 1992 to November 1995 in France Full-term pregnant women in eight centers were randomized double-blind placebo-controlled study. Select the study object for singleton pregnancies, first Xianlu, gestational age 37 to 41 weeks plus 3d, cervical immature, within 48h (